Seegene Advances Global PCR Diagnostics with GMCS Study
Seoul, South Korea, August 5, 2026 Seegene Inc., a global leader in molecular diagnostics, has unveiled a comprehensive PCR-based...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Seoul, South Korea, August 5, 2026 Seegene Inc., a global leader in molecular diagnostics, has unveiled a comprehensive PCR-based...
MILFORD, Mass., April 8, 2026 Waters Corporation has announced U.S. FDA clearance for its Onclarityâ„¢ HPV Self-Collection Kit, enabling...
